A global strategy to tackle antibacterial drug resistance has been announced by the WHO's director general

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.332, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A new funding initiative has been announced in South Korea

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 345, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Antibacterial resistance: who pays?

By Boggs Amy F

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 8, 2003-08 ,pp. : 1107-1112

Informa Healthcare

Access to resources Recommend Favorite

The timing of preoperative antibacterial administration has been improved

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 274, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

DOV Pharmaceuticals has announced that dosing has been suspended in its ongoing trial of ocinaplon due to liver enzyme elevations

Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Global analysis of strategies to tackle antimicrobial resistance

International Journal Of Pharmacy Practice, Vol. 26, Iss. 1, 2018-02 ,pp. : 85-89

John Wiley & Sons Inc

Access to resources Recommend Favorite